Skip to main content

Postchemotherapy Morphological MR Imaging

  • Chapter
  • First Online:
  • 437 Accesses

Abstract

Neurotoxicity of drugs is a pathological entity in growth for the wider use of specific antiblastic therapies and also for better clinical and neuroradiological performance that allow early and specific diagnosis.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Brandes AA, Franceschi E, Tosoni A, et al. MGMT promoter methylation status can predict the incidence and out come of pseudoprogression after concomitant radiochemiotherapy in newly diagnosed glioblastoma patients. J Clin Oncol. 2008;26(13):2192–7.

    Article  Google Scholar 

  2. Brandsma D, Stalpers L, Taal, et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9(5):453–61.

    Article  Google Scholar 

  3. Sanghera P, Perry J, Sahgal A, et al. Pseudoprogression following chemoradiotherapy for glioblastoma multiforme. Can J Neurol Sci. 2010;37:36–42.

    Article  Google Scholar 

  4. Stupp R, Hegi M. Methylguanine methyltransferase testing in glioblastoma: when and how ? J Clin Oncol. 2007;25:1459–60.

    Article  Google Scholar 

  5. Forster VJ, McDonnell A, Theobald R, et al. Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity. Epigenomics. 2017;9(9):1205–18.

    Article  CAS  Google Scholar 

  6. Macdonald DR, Cascino TL, Schold SC, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8:1277–80.

    Article  CAS  Google Scholar 

  7. Magge RS, DeAngelis LM. The double-edged sword: neurotoxicity of chemotherapy. Blood Rev. 2015;29(2):93–100.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Popolizio, T., Izzo, R., Balzano, R.F., Pennelli, A.M. (2020). Postchemotherapy Morphological MR Imaging. In: Scarabino, T., Pollice, S. (eds) Imaging Gliomas After Treatment. Springer, Cham. https://doi.org/10.1007/978-3-030-31210-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-31210-7_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-31209-1

  • Online ISBN: 978-3-030-31210-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics